Quarterly report · Q1
3750.TEDINET S100RO02
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥472m | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥2.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥544m | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | −¥137m | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | −¥163m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | −¥169m | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥862m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥186m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥166m | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥294m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥161m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥288m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥161m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | −¥288m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥13.9bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥14.1bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥14.5bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥11.4bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥11.4bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.5bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥2.7bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.4bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥887m | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-18.07 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-118.71 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-32.21 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 16.5% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.1% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-06-30 | −¥41m |
| jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥26m |
| jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥26m |
| jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segment | segment profit | 2023-04-01 → 2023-06-30 | −¥157m |
| jpcrp040300-q1r_E05443-000Real Asset Managementreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥446m |
| jpcrp040300-q1r_E05443-000Real Asset Managementreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥446m |
| jpcrp040300-q1r_E05443-000Real Asset Managementreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥62m |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥472m |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥472m |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | −¥96m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥38m |
| jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥37m |
| jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥37m |
| jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segment | segment profit | 2022-04-01 → 2022-06-30 | −¥47m |
| jpcrp040300-q1r_E05443-000Real Asset Managementreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥507m |
| jpcrp040300-q1r_E05443-000Real Asset Managementreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥507m |
| jpcrp040300-q1r_E05443-000Real Asset Managementreportable segment | segment profit | 2022-04-01 → 2022-06-30 | −¥78m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥544m |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥544m |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | −¥125m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 312
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E05443-000MedicalAssetManagemetReportableSegmentsMember | 36830000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E05443-000RealAssetManagementReportableSegmentsMember | 506708000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 543539000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Net sales | Prior1YTDDuration | 543539000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E05443-000MedicalAssetManagemetReportableSegmentsMember | -46547000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E05443-000RealAssetManagementReportableSegmentsMember | -78002000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | -124549000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -37987000 | JPY |
| Operating income | Prior1YTDDuration | -162537000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E05443-000MedicalAssetManagemetReportableSegmentsMember | 26354000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E05443-000RealAssetManagementReportableSegmentsMember | 446121000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 472475000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 472475000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E05443-000MedicalAssetManagemetReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E05443-000RealAssetManagementReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E05443-000MedicalAssetManagemetReportableSegmentsMember | 26354000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E05443-000RealAssetManagementReportableSegmentsMember | 446121000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 472475000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Net sales | CurrentYTDDuration | 472475000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E05443-000MedicalAssetManagemetReportableSegmentsMember | -157330000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E05443-000RealAssetManagementReportableSegmentsMember | 61669000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | -95660000 | JPY |
| Operating income | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -41469000 | JPY |
| Operating income | CurrentYTDDuration | -137130000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-08-10 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第20期第１四半期（自 2023年４月１日 至 2023年６月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社サイトリ細胞研究所 | |
| Company name in english cover page | FilingDateInstant | Cytori Cell Research Institute,Inc. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 星野 喜宏 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都千代田区大手町一丁目１番１号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03－6860－5701 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役経営企画部長 藤村 剛 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都千代田区大手町一丁目１番１号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03－6860－5701 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役経営企画部長 藤村 剛 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E05443 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 37500 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社サイトリ細胞研究所 | |
| Filer name in english | FilingDateInstant | Cytori Cell Research Institute,Inc. |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |